You can tell Patterson doesn't believe the 13d will take over Cytodyn when in his presentation in Italy he fails to mention leronlimab even when citing 58 out of 60 critical patients saved, 10 on ECMO from the early EIND studies. If he believed he would gain control of leronlimab he would be promoting it.